ClinicalTrials.Veeva

Menu

Cardiovascular Registry of Atrial Fibrillation (LACROSS)

B

Brazilian Clinical Research Institute

Status

Completed

Conditions

Atrial Flutter
Atrial Fibrillation

Treatments

Other: Patient Registry Data

Study type

Observational

Funder types

Other

Identifiers

NCT04456842
001/2018

Details and patient eligibility

About

Follow a representative sample of Latin American patients diagnosed with atrial fibrillation to set data on demographic characteristics, documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death

Full description

Patients will be followed 6 months and 1 year after the baseline visit and will be collected data of antithrombotic therapy, laboratory data, discontinuation rates of antithrombotic therapy and clinical outcomes.

Enrollment

2,016 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years-old that signed informed consent;
  • Atrial Fibrillation or Atrial Flutter at the time of inclusion documented in source document;
  • If the patient is not in atrial fibrillation or Atrial Flutter rhythm, s/he should have 2 electrographic records, at least 15 days apart between them, with one of them being performed within the last 6 months before enrollment (AF may be documented by 12-lead ECG, Holter monitor-24h);

Exclusion criteria

  • Patients who did not agree to participate.
  • Patients without possibility of monitoring for one year.

Trial contacts and locations

17

Loading...

Central trial contact

Renato D. Lopes, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems